A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

From sweeping drug price reforms to proposed staffing mandates and changes to Medicaid financing, here are five federal policy moves from the last week that ASCs need to know: CMS proposes updates for ...

As of now, commissions on renewals will continue to be paid. Also, Leapfrog has served a cease-and-desist after Tenet Healthcare Corp. filed a lawsuit alleging that the safety grades process was ...

Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down as the Danish drug giant faces increased competition for its ...

This month, the Centers for Medicare and Medicaid Services will begin meeting with patients who use the 15 drugs it selected ...

For decades, Americans have been overpaying for prescriptions and subsidizing innovation for the rest of the world. The White ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

For the first time in history, Medicare has the power to negotiate the price it pays for some of the costliest and most-used ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

President Donald Trump signed an Executive Order (EO) titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” aimed ...

President Trump signed an executive order Monday that will attempt to bring the down the cost of some drugs in the United ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...